BNP PARIBAS FINANCIAL MARKETS - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 156 filers reported holding ASSERTIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$14,277,000
-34.5%
21,965
+26.0%
0.00%
Q4 2019$21,796,000
+73.0%
17,437
+77.1%
0.00%
Q3 2019$12,600,000
-45.5%
9,844
+46.9%
0.00%
Q2 2019$23,125,000
-63.2%
6,703
-45.9%
0.00%
Q1 2019$62,762,000
+15709.1%
12,379
+11153.6%
0.00%
Q4 2018$397,000
-97.5%
110
-96.0%
0.00%
Q3 2018$15,988,0002,7190.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Senvest Management, LLC 5,006,637$29,439,0002.23%
ARMISTICE CAPITAL, LLC 3,000,000$17,640,0001.06%
DELTEC ASSET MANAGEMENT LLC 517,606$3,044,0000.58%
PERKINS CAPITAL MANAGEMENT INC 125,550$738,0000.44%
Matarin Capital Management, LLC 600,223$3,529,311,0000.23%
GLOBEFLEX CAPITAL L P 196,615$1,156,0000.23%
ALGERT GLOBAL LLC 139,129$818,0000.18%
TSP Capital Management Group, LLC 53,575$315,0000.16%
CORNERCAP INVESTMENT COUNSEL INC 157,235$925,0000.12%
Connor, Clark & Lunn Investment Management Ltd. 3,060,189$17,994,0000.10%
View complete list of ASSERTIO THERAPEUTICS INC shareholders